サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：セルライト治療市場 - 2027年までの予測
市場調査レポート
商品コード
1074665

セルライト治療市場 - 2027年までの予測

Cellulite Treatment Market Research Report-Forecast to 2027
出版日: | 発行: Market Research Future | ページ情報: 英文 95 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.53円
セルライト治療市場 - 2027年までの予測
出版日: 2022年05月10日
発行: Market Research Future
ページ情報: 英文 95 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のセルライト治療の市場規模は、今後、8.97%のCAGRで拡大し、2027年末までに10億8,644万米ドルを超えると予測されています。

当レポートでは、世界のセルライト治療市場について調査し、市場の概要とともに、治療手技別、セルライトタイプ別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場のイントロダクション

第3章 調査手法

第4章 市場力学

  • 概要
  • 促進要因
    • 世界的な肥満症例数の増加
    • 美容整形手術に対する需要の高まり
    • 成長するメディカルツーリズム産業
  • 抑制要因
    • あざや腫れに関する懸念
    • 訓練を受けた経験豊富な皮膚科医/形成外科医の不足
  • 機会
    • 新興経済国における美容整形手術の採用拡大

第5章 市場要因分析

  • バリューチェーン分析
  • ポーターのファイブフォースモデル
  • COVID-19が世界のセルライト治療市場に与える影響

第6章 世界のセルライト治療市場、治療手技別

  • 概要
  • 非侵襲性
  • 局所
  • 低侵襲性
  • その他

第7章 世界のセルライト治療市場、セルライトタイプ別

  • 概要
  • ソフトセルライト
  • ハードセルライト
  • 浮腫性セルライト

第8章 世界のセルライト治療市場、エンドユーザー別

  • 概要
  • 病院
  • 皮膚科専門クリニック
  • 外来外科センター
  • その他

第9章 世界のセルライト治療市場、地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他
  • その他の地域
    • 中東
    • アフリカ
    • ラテンアメリカ

第10章 競合情勢

第11章 企業プロファイル

  • HOLOGIC, INC.
  • NUBWAY CO.LTD.
  • MERZ PHARMA GMBH & CO. KGAA
  • ZIMMER AESTHETICS
  • CYMEDICS
  • CYNOSURE, LLC
  • INCELER MEDIKAL CO. LTD.
  • CANDELA MEDICAL
  • CUTERA, INC.
  • BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.

第12章 付録

図表

LIST OF TABLES

  • TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
  • TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • TABLE 3 GLOBAL: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 4 GLOBAL: CELLULITE TREATMENT MARKET, FOR NON-INVASIVE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 5 GLOBAL: CELLULITE TREATMENT MARKET, FOR TOPICAL, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 6 GLOBAL: CELLULITE TREATMENT MARKET, FOR MINIMALLY INVASIVE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 7 GLOBAL: CELLULITE TREATMENT MARKET, FOR OTHERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 8 GLOBAL: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 9 GLOBAL: CELLULITE TREATMENT MARKET, FOR SOFT CELLULITE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 10 GLOBAL: CELLULITE TREATMENT MARKET, FOR HARD CELLULITE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 11 GLOBAL: CELLULITE TREATMENT MARKET, FOR EDEMATOUS CELLULITE, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 12 GLOBAL: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 13 GLOBAL: CELLULITE TREATMENT MARKET, FOR HOSPITALS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 14 GLOBAL: CELLULITE TREATMENT MARKET, FOR SPECIALISED DERMATOLOGY CLINICS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 15 GLOBAL: CELLULITE TREATMENT MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 16 GLOBAL: CELLULITE TREATMENT MARKET, FOR OTHERS, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 17 GLOBAL: CELLULITE TREATMENT MARKET, BY REGION, 2018-2027 (USD MILLION)
  • TABLE 18 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 19 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 20 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 21 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 22 US: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 23 US: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 24 US: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 25 CANADA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 26 CANADA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 27 CANADA: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 28 EUROPE: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 29 EUROPE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 30 EUROPE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 31 EUROPE: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 32 GERMANY: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 33 GERMANY: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 34 GERMANY: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 35 UK: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 36 UK: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 37 UK: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 38 FRANCE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 39 FRANCE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 40 FRANCE: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 41 ITALY: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 42 ITALY: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 43 ITALY: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 44 SPAIN: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 45 SPAIN: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 46 SPAIN: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 47 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 48 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 49 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 50 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 53 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 54 CHINA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 55 CHINA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 56 CHINA: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 57 JAPAN: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 58 JAPAN: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 59 JAPAN: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 60 INDIA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 61 INDIA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 62 INDIA: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 63 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 64 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 65 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 66 AUSTRALIA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 67 AUSTRALIA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 68 AUSTRALIA: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 69 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 70 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 71 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 72 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 73 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 74 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 75 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 76 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 77 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 78 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 79 AFRICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 80 AFRICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 81 AFRICA: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 82 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018-2027 (USD MILLION)
  • TABLE 83 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018-2027 (USD MILLION)
  • TABLE 84 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 85 MAJOR PLAYERS IN THE GLOBAL CELLULITE TREATMENT MARKET
  • TABLE 86 MOST ACTIVE PLAYER IN THE GLOBAL CELLULITE TREATMENT MARKET
  • TABLE 87 PRODUCT LAUNCH/PRODUCT APPROVAL
  • TABLE 88 HOLOGIC, INC: PRODUCTS/SERVICES OFFERED
  • TABLE 89 NUBWAY CO.LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 90 MERZ PHARMA GMBH & CO. KGAA: PRODUCTS/SERVICES OFFERED
  • TABLE 91 ZIMMER AESTHETICS: PRODUCTS/SERVICES OFFERED
  • TABLE 92 CYMEDICS: PRODUCTS/SERVICES OFFERED
  • TABLE 93 CYNOSURE, LLC: PRODUCTS/SERVICES OFFERED
  • TABLE 94 INCELER MEDIKAL CO. LTD.: PRODUCTS/SERVICES OFFERED
  • TABLE 95 CANDELA MEDICAL: PRODUCTS/SERVICES OFFERED
  • TABLE 96 CUTERA, INC.: PRODUCTS/SERVICES OFFERED
  • TABLE 97 CUTERA, INC.: KEY DEVELOPMENTS
  • TABLE 98 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.: PRODUCTS/SERVICES OFFERED

LIST OF FIGURES

  • FIGURE 1 MARKET SYNOPSIS
  • FIGURE 2 MARKET STRUCTURE: GLOBAL CELLULITE TREATMENT MARKET
  • FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
  • FIGURE 4 MARKET DYNAMICS: GLOBAL CELLULITE TREATMENT MARKET
  • FIGURE 5 DRIVER IMPACT ANALYSIS
  • FIGURE 6 RESTRAINT IMPACT ANALYSIS
  • FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL CELLULITE TREATMENT MARKET
  • FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CELLULITE TREATMENT MARKET
  • FIGURE 9 GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2020 & 2027 (USD MILLION)
  • FIGURE 10 GLOBAL: CELLULITE TREATMENT MARKET, CELLULITE TYPE, 2020 & 2027 (USD MILLION)
  • FIGURE 11 GLOBAL: CELLULITE TREATMENT MARKET, END USER, 2020 & 2027 (USD MILLION)
  • FIGURE 12 GLOBAL: CELLULITE TREATMENT MARKET, BY REGION 2020 & 2027 (USD MILLION)
  • FIGURE 13 GLOBAL: CELLULITE TREATMENT MARKET SHARE (%), BY REGION, 2020
  • FIGURE 14 NORTH AMERICA: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020
  • FIGURE 15 EUROPE: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020
  • FIGURE 16 ASIA PACIFIC: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020
  • FIGURE 17 REST OF THE WORLD: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020
  • FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS
  • FIGURE 19 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CELLULITE TREATMENT MARKET
  • FIGURE 20 HOLOGIC, INC: FINANCIAL OVERVIEW SNAPSHOT
  • FIGURE 21 HOLOGIC, INC: SWOT ANALYSIS
  • FIGURE 22 NUBWAY CO.LTD.: SWOT ANALYSIS
  • FIGURE 23 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS
  • FIGURE 24 ZIMMER AESTHETICS: SWOT ANALYSIS
  • FIGURE 25 CYMEDICS: SWOT ANALYSIS
目次
Product Code: MRFR/HC/7665-CR

Market Forecast

As per the MRFR analysis, the global cellulite treatment market is projected to register a notable market growth at a CAGR of 8.97% during the forecast period to record a largest market value of USD 1,086.44 million by the end of. Cellulite is the dimpled skin disorder that causes uneven, dimpled tissue on the thighs, rear end hips, and midsection. There are different treatments are accessible to work on the presence of cellulite. The global market expansion is attributed to the rising interest for stylish and corrective techniques, Expanding umber of corpulent cases across the globe.

The global cellulite treatment market is anticipated to witness a significant market expansion owing to the rising number of hefty cases across the globe, rising interest for tasteful and corrective systems and developing clinical the travel industry. Developing reception of restorative techniques in arising economies is supposed to help the development of cellulite treatment market. Nonetheless, concerns relating to swelling and enlarging post treatment and lack of prepared and experienced dermatologist/plastic specialist is expected to hamper the market development.

Segment Overview

Global Cellulite Treatment Market is classified into treatment procedures, cellulite type, and region. In terms of treatment procedures, the global market is categorized into Non-Invasive, Minimally Invasive, and Topical.

The Cellulite type segment divides the market into Soft Cellulite, Hard Cellulite, and Edematous Cellulite.

Regional Analysis

Geographically, the global cellulite treatment market is studied across five major segments namely North America, Europe, Asia-Pacific, and Rest of the world.

North America is estimated to dominate the market owing to the largest market of US; it holds the most outrageous regional market of around 92.80% of the all-out market, enlisting USD 218.47 million market size in 2020. The locale is supposed to hold the largest market share of the overall business in the base year inferable from the presence of many major market players across the district, an expanding number of thing dispatches in the area, and expanding care about various sorts of cellulite treatment among the young populace. The business players have placed enormous capital in developing new advancements, gadgets, treatments, and injectables.

Asia Pacific is supposed to select the speediest CAGR of 10.98% during the figure time period from 2021 to 2027. This is because of expanding revenue in innovative headway, rising speculation of market players in R&D activities to encourage new treatment gadgets, creating revenue for spas and health centers, expanding care programs through internet-based entertainment channels across the area, and long stationary working hours. The ascent in stationary working hours is the significant justification for cellulite collection among used ladies in Asia Pacific. Such a way of life is accelerating the treatment of cellulite evacuation among young female specialists. Mesotherapy is the most famous cellulite treatment strategy in Japan.

Key Players

The prominent players in the global cellulite treatment market are Hologic, Inc. (US), Merz Pharma GmbH & Co. KGaA (Germany), Inceler Medikal Co. Ltd (Turkey), Candela Medical (US), Cutera, Inc (US), Zimmer Aesthetics (Germany), Nubway Co.Ltd. (China), Cymedics (Germany), Cynosure, Inc (US), and Beijing Sincoheren S & T Development Co., Ltd (China).

COVID 19 Impacts

We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

  • 2.1 SCOPE OF THE STUDY
  • 2.2 RESEARCH OBJECTIVE
  • 2.3 MARKET STRUCTURE
  • 2.4 ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

  • 3.1 DATA MINING
  • 3.2 SECONDARY RESEARCH
  • 3.3 PRIMARY RESEARCH
  • 3.4 BREAKDOWN OF PRIMARY RESPONDENTS
  • 3.5 FORECASTING TECHNIQUES
  • 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
    • 3.6.1 BOTTOM-UP APPROACH
    • 3.6.2 TOP-DOWN APPROACH
  • 3.7 DATA TRIANGULATION
  • 3.8 VALIDATION

4 MARKET DYNAMICS

  • 4.1 OVERVIEW
  • 4.2 DRIVERS
    • 4.2.1 INCREASING NUMBER OF OBESE CASES ACROSS THE GLOBE
    • 4.2.2 RISING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
    • 4.2.3 GROWING MEDICAL TOURISM INDUSTRY
  • 4.3 RESTRAINTS
    • 4.3.1 CONCERNS PERTAINING TO BRUISING AND SWELLING
    • 4.3.2 SHORTAGE OF TRAINED AND EXPERIENCED DERMATOLOGIST/ PLASTIC SURGEON
  • 4.4 OPPORTUNITY
    • 4.4.1 GROWING ADOPTION OF COSMETIC PROCEDURES IN EMERGING ECONOMIES

5 MARKET FACTOR ANALYSIS

  • 5.1 VALUE CHAIN ANALYSIS
    • 5.1.1 R&D
    • 5.1.2 MANUFACTURING
    • 5.1.3 DISTRIBUTION AND SALES
    • 5.1.4 POST-SALES MONITORING
  • 5.2 PORTER'S FIVE FORCES MODEL
    • 5.2.1 BARGAINING POWER OF SUPPLIERS
    • 5.2.2 BARGAINING POWER OF BUYERS
    • 5.2.3 THREAT OF NEW ENTRANTS
    • 5.2.4 THREAT OF SUBSTITUTES
    • 5.2.5 INTENSITY OF RIVALRY
  • 5.3 IMPACT OF COVID-19 ON THE GLOBAL CELLULITE TREATMENT MARKET
    • 5.3.1 IMPACT ON SUPPLY CHAIN
    • 5.3.2 IMPACT ON PATIENTS SUFFERING FROM CELLULITE
    • 5.3.3 IMPACT ON DEMAND AND SUPPLY
    • 5.3.4 IMPACT ON REGIONS

6 GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE

  • 6.1 OVERVIEW
  • 6.2 NON-INVASIVE
  • 6.3 TOPICAL
  • 6.4 MINIMALLY INVASIVE
  • 6.5 OTHERS

7 GLOBAL CELLULITE TREATMENT MARKET, BY CELLULITE TYPE

  • 7.1 OVERVIEW
  • 7.2 SOFT CELLULITE
  • 7.3 HARD CELLULITE
  • 7.4 EDEMATOUS CELLULITE

8 GLOBAL CELLULITE TREATMENT MARKET, BY END USER

  • 8.1 OVERVIEW
  • 8.2 HOSPITALS
  • 8.3 SPECIALISED DERMATOLOGY CLINICS
  • 8.4 AMBULATORY SURGICAL CENTERS
  • 8.5 OTHERS

9 GLOBAL CELLULITE TREATMENT MARKET, BY REGION

  • 9.1 OVERVIEW
  • 9.2 NORTH AMERICA
    • 9.2.1 US
    • 9.2.2 CANADA
  • 9.3 EUROPE
    • 9.3.1 GERMANY
    • 9.3.2 UK
    • 9.3.3 FRANCE
    • 9.3.4 ITALY
    • 9.3.5 SPAIN
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
    • 9.4.2 JAPAN
    • 9.4.3 INDIA
    • 9.4.4 SOUTH KOREA
    • 9.4.5 AUSTRALIA
    • 9.4.6 REST OF ASIA PACIFIC
  • 9.5 REST OF THE WORLD
    • 9.5.1 MIDDLE EAST
    • 9.5.2 AFRICA
    • 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 COMPETITIVE BENCHMARKING
  • 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CELLULITE TREATMENT MARKET
  • 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL CELLULITE TREATMENT MARKET
  • 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
    • 10.5.1 PRODUCT LAUNCH/PRODUCT APPROVAL

11 COMPANY PROFILES

  • 11.1 HOLOGIC, INC.
    • 11.1.1 COMPANY OVERVIEW
    • 11.1.2 FINANCIAL OVERVIEW
    • 11.1.3 PRODUCTS/SERVICES OFFERED
    • 11.1.4 KEY DEVELOPMENTS
    • 11.1.5 SWOT ANALYSIS
    • 11.1.6 KEY STRATEGIES
  • 11.2 NUBWAY CO.LTD.
    • 11.2.1 COMPANY OVERVIEW
    • 11.2.2 FINANCIAL OVERVIEW
    • 11.2.3 PRODUCTS/SERVICES OFFERED
    • 11.2.4 KEY DEVELOPMENTS
    • 11.2.5 SWOT ANALYSIS
    • 11.2.6 KEY STRATEGIES
  • 11.3 MERZ PHARMA GMBH & CO. KGAA
    • 11.3.1 COMPANY OVERVIEW
    • 11.3.2 FINANCIAL OVERVIEW
    • 11.3.3 PRODUCTS/SERVICES OFFERED
    • 11.3.4 KEY DEVELOPMENTS
    • 11.3.5 SWOT ANALYSIS
    • 11.3.6 KEY STRATEGIES
  • 11.4 ZIMMER AESTHETICS
    • 11.4.1 COMPANY OVERVIEW
    • 11.4.2 FINANCIAL OVERVIEW
    • 11.4.3 PRODUCTS/SERVICES OFFERED
    • 11.4.4 KEY DEVELOPMENTS
    • 11.4.5 SWOT ANALYSIS
    • 11.4.6 KEY STRATEGIES
  • 11.5 CYMEDICS
    • 11.5.1 COMPANY OVERVIEW
    • 11.5.2 FINANCIAL OVERVIEW
    • 11.5.3 PRODUCTS/SERVICES OFFERED
    • 11.5.4 KEY DEVELOPMENTS
    • 11.5.5 SWOT ANALYSIS
    • 11.5.6 KEY STRATEGIES
  • 11.6 CYNOSURE, LLC
    • 11.6.1 COMPANY OVERVIEW
    • 11.6.2 FINANCIAL OVERVIEW
    • 11.6.3 PRODUCTS/SERVICES OFFERED
    • 11.6.4 KEY DEVELOPMENTS
    • 11.6.5 KEY STRATEGIES
  • 11.7 INCELER MEDIKAL CO. LTD.
    • 11.7.1 COMPANY OVERVIEW
    • 11.7.2 FINANCIAL OVERVIEW
    • 11.7.3 PRODUCTS/SERVICES OFFERED
    • 11.7.4 KEY DEVELOPMENTS
    • 11.7.5 KEY STRATEGIES
  • 11.8 CANDELA MEDICAL
    • 11.8.1 COMPANY OVERVIEW
    • 11.8.2 FINANCIAL OVERVIEW
    • 11.8.3 PRODUCTS/SERVICES OFFERED
    • 11.8.4 KEY DEVELOPMENTS
    • 11.8.5 KEY STRATEGIES
  • 11.9 CUTERA, INC.
    • 11.9.1 COMPANY OVERVIEW
    • 11.9.2 FINANCIAL OVERVIEW
    • 11.9.3 PRODUCTS/SERVICES OFFERED
    • 11.9.4 KEY DEVELOPMENTS
    • 11.9.5 KEY STRATEGIES
  • 11.10 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.
    • 11.10.1 COMPANY OVERVIEW
    • 11.10.2 FINANCIAL OVERVIEW
    • 11.10.3 PRODUCTS/SERVICES OFFERED
    • 11.10.4 KEY DEVELOPMENTS
    • 11.10.5 KEY STRATEGIES

12 APPENDIX

  • 12.1 REFERENCES
  • 12.2 RELATED REPORTS